RecruitingNCT03981575
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Studying Myotonic dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Virginia Commonwealth University
- Principal Investigator
- Nicholas Johnson, MDVirginia Commonwealth University
- Enrollment
- 700 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2019 – 2026
Study locations (17)
- University of California, San Diego, La Jolla, California, United States
- University of California, Los Angeles, Los Angeles, California, United States
- University of Colorado - Denver, Denver, Colorado, United States
- University of Florida, Gainesville, Florida, United States
- University of Iowa, Iowa City, Iowa, United States
- Kansas University Medical Center, Kansas City, Kansas, United States
- University of Rochester, Rochester, New York, United States
- Ohio State University, Columbus, Ohio, United States
- Houston Methodist Neurological Institute, Houston, Texas, United States
- Virginia Commonwealth University, Richmond, Virginia, United States
- Université de Sherbrooke, Québec, Canada
- Friedrich Baur Institute, Ludwig-Maximilians-Universität München, München, Germany
- Centro Clinico NeMO, Milan, Italy
- Radboud University Medical Center, Nijmegen, Netherlands
- University of Auckland, Auckland, New Zealand
- +2 more locations on ClinicalTrials.gov
Collaborators
University of Rochester · Stanford University · Ohio State University · University of Florida · University of Iowa · Ludwig-Maximilians - University of Munich · Fondazione Serena Onlus - Centro Clinico NeMO Milano · The Methodist Hospital Research Institute · Radboud University Medical Center · University College London Hospitals · University of California, Los Angeles
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03981575 on ClinicalTrials.govOther trials for Myotonic dystrophy
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07486934Efficacy, Safety, and Tolerability of DYNE-101 in Participants With Myotonic Dystrophy Type 1Dyne Therapeutics
- RECRUITINGPHASE2NCT07220603An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)PepGen Inc
- ACTIVE NOT RECRUITINGNCT07493525Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1Antalya Training and Research Hospital
- RECRUITINGNCT06747884Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy ExtensionVirginia Commonwealth University
- RECRUITINGNCT07385443The Spanish National Registry for Myotonic Dystrophy Type 1Fundació Institut Germans Trias i Pujol
- RECRUITINGNCT07362875Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic DystrophyWake Forest University Health Sciences
- RECRUITINGNANCT06809049Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)Hanns Lochmuller
- RECRUITINGPHASE2NCT06667453A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1PepGen Inc